Replies to post #32578 on Cel Sci Corporation (CVM)

[Proxima]

I take it from this tweet on July 1st that only 1 team is left to report results: "Our independent team is still working on the data for our Phase 3 clinical trial with Multikine in head and neck cancer. Once they are done we will be told the results and we will share those with you. In the meantime we are blinded and have to wait"

#cel_sci #CVM $CVM Our independent team is still working on the data for our Phase 3 clinical trial with Multikine in head and neck cancer. Once they are done we will be told the results and we will share those with you. In the meantime we are blinded and have to wait.

— CEL-SCI Corporation (@CelSciCorp) July 1, 2020

I take this to mean that Icon is done, just the independent team that was also hired to analyze the data is left to report.

What happens if these teams disagree?
They will have to have a meeting and reconcile.
That could take a while, let's hope they both get the same results.

[BRMachine]

Robot, I understand your frustration, but please step away from the ledge.

The length of time it takes to achieve data lock and analyze results is not an indicator of failure. For years it’s only been about the success or failure of Multikine, not how long it takes to get there.

The COVID-19 pandemic is unprecedented and has created enormous challenges to almost all aspects of business. Is it not unreasonable to think that COVID alone could account for delays that even Geert couldn’t predict?

I am anxious for results, especially given the time and money I’ve invested in this stock, but the evidence still points to success, in my opinion.